Skip to content

Clinical trials

Uterine Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Country / region: Canada Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20061
20125
20131
20151
20171
20181
20201
20211
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Unknown status3
Terminated2
Not yet recruiting1
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
AstraZeneca2
Sunnybrook Health Sciences Centre2
Elevation Oncology1
Fore Biotherapeutics1
GAAD Medical Research Institute Inc.1
Hamilton Health Sciences Corporation1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Karyopharm Therapeutics Inc1
Nova Scotia Health Authority1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms21
Endometrial Neoplasms10
Ovarian Neoplasms7
Uterine Cervical Neoplasms7
Neoplasms5
Breast Neoplasms4
Neoplasm Metastasis4
Urinary Bladder Neoplasms3
Vaginal Neoplasms3
Cholangiocarcinoma2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.